Chemoinformaics analysis of UNII-15X09F2755
Molecular Weight | 220.356 | nRot | 4 |
Heavy Atom Molecular Weight | 196.164 | nRig | 10 |
Exact Molecular Weight | 220.183 | nRing | 4 |
Solubility: LogS | -4.228 | nHRing | 0 |
Solubility: LogP | 3.992 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 4 | No. Saturated Carbocycles | 4 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 4 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 41.855 |
nHD | 1 | BPOL | 24.077 |
QED | 0.72 |
Synth | 5.353 |
Natural Product Likeliness | 3.408 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.001 |
Pgp-sub | 0 |
HIA | 0.004 |
CACO-2 | -4.447 |
MDCK | 0.0000152 |
BBB | 0.923 |
PPB | 0.920553 |
VDSS | 2.234 |
FU | 0.0944768 |
CYP1A2-inh | 0.272 |
CYP1A2-sub | 0.288 |
CYP2c19-inh | 0.266 |
CYP2c19-sub | 0.844 |
CYP2c9-inh | 0.279 |
CYP2c9-sub | 0.665 |
CYP2d6-inh | 0.02 |
CYP2d6-sub | 0.425 |
CYP3a4-inh | 0.223 |
CYP3a4-sub | 0.233 |
CL | 15.765 |
T12 | 0.136 |
hERG | 0.022 |
Ames | 0.008 |
ROA | 0.048 |
SkinSen | 0.534 |
Carcinogencity | 0.096 |
EI | 0.943 |
Respiratory | 0.884 |
NR-Aromatase | 0.073 |
Antiviral | Yes |
Prediction | 0.796244 |